GlycoMimetics Analyst Ratings
GlycoMimetics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/15/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 05/04/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 03/30/2023 | 403.14% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 02/16/2023 | 403.14% | HC Wainwright & Co. | $13 → $8 | Maintains | Buy |
| 08/04/2022 | 717.61% | HC Wainwright & Co. | $14 → $13 | Maintains | Buy |
| 11/12/2021 | 151.57% | Jefferies | $3 → $4 | Upgrades | Hold → Buy |
| 12/08/2020 | 843.4% | Roth Capital | $9 → $15 | Maintains | Buy |
| 07/31/2020 | 843.4% | HC Wainwright & Co. | $16 → $15 | Maintains | Buy |
| 03/02/2020 | 906.29% | HC Wainwright & Co. | $18 → $16 | Reiterates | → Buy |
| 11/14/2019 | 654.72% | Roth Capital | → $12 | Initiates Coverage On | → Buy |
| 08/05/2019 | — | Jefferies | Downgrades | Buy → Hold | |
| 08/05/2019 | 214.47% | SunTrust Robinson Humphrey | $23 → $5 | Downgrades | Buy → Hold |
| 08/05/2019 | 277.36% | Piper Sandler | $20 → $6 | Downgrades | Overweight → Neutral |
| 04/12/2019 | — | Piper Sandler | Initiates Coverage On | → Overweight | |
| 12/18/2018 | 1409.43% | HC Wainwright & Co. | → $24 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/03/2023 | 403.14% | HC Wainwright & Co. | → 8 美元 | 重申 | 购买 → 购买 |
| 06/15/2023 | 403.14% | HC Wainwright & Co. | → 8 美元 | 重申 | → 购买 |
| 05/04/2023 | 403.14% | HC Wainwright & Co. | → 8 美元 | 重申 | → 购买 |
| 03/30/2023 | 403.14% | HC Wainwright & Co. | → 8 美元 | 重申 | → 购买 |
| 02/16/2023 | 403.14% | HC Wainwright & Co. | 13 美元 → 8 美元 | 维护 | 购买 |
| 08/04/2022 | 717.61% | HC Wainwright & Co. | 14 美元 → 13 美元 | 维护 | 购买 |
| 11/12/2021 | 151.57% | 杰富瑞 | 3 美元 → 4 美元 | 升级 | 持有 → 买入 |
| 12/08/2020 | 843.4% | 罗斯资本 | 9 美元 → 15 美元 | 维护 | 购买 |
| 2020 年 7 月 31 日 | 843.4% | HC Wainwright & Co. | 16 美元 → 15 美元 | 维护 | 购买 |
| 03/02/2020 | 906.29% | HC Wainwright & Co. | 18 美元 → 16 美元 | 重申 | → 购买 |
| 2019 年 11 月 14 日 | 654.72% | 罗斯资本 | → 12 美元 | 启动覆盖开启 | → 购买 |
| 2019 年 5 月 8 日 | — | 杰富瑞 | 降级 | 买入 → 持有 | |
| 2019 年 5 月 8 日 | 214.47% | SunTrust 罗宾逊汉弗莱 | 23 美元 → 5 美元 | 降级 | 买入 → 持有 |
| 2019 年 5 月 8 日 | 277.36% | 派珀·桑德勒 | 20 美元 → 6 美元 | 降级 | 超重 → 中性 |
| 2019 年 12 月 4 日 | — | 派珀·桑德勒 | 启动覆盖开启 | → 超重 | |
| 12/18/2018 | 1409.43% | HC Wainwright & Co. | → 24 美元 | 启动覆盖开启 | → 购买 |
What is the target price for GlycoMimetics (GLYC)?
GlycoMimetics (GLYC) 的目标价格是多少？
The latest price target for GlycoMimetics (NASDAQ: GLYC) was reported by HC Wainwright & Co. on August 3, 2023. The analyst firm set a price target for $8.00 expecting GLYC to rise to within 12 months (a possible 403.14% upside). 6 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年8月3日公布了GlycoMimetics（纳斯达克股票代码：GLYC）的最新目标股价。这家分析公司将目标股价定为8.00美元，预计GLYC将在12个月内上涨至403.14％（可能上涨403.14％）。去年有6家分析公司公布了评级。
What is the most recent analyst rating for GlycoMimetics (GLYC)?
分析师对GlycoMimetics（GLYC）的最新评级是多少？
The latest analyst rating for GlycoMimetics (NASDAQ: GLYC) was provided by HC Wainwright & Co., and GlycoMimetics reiterated their buy rating.
GlycoMimetics（纳斯达克股票代码：GLYC）的最新分析师评级由HC Wainwright & Co. 提供，GlycoMimetics重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for GlycoMimetics (GLYC)?
GlycoMimetics（GLYC）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GlycoMimetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GlycoMimetics was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析师在进行了广泛的研究（包括浏览公开财务报表、与GlycoMimetics的高管和客户交谈以及听取财报电话会议）后得出股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。GlycoMimetics的最新评级是在2023年8月3日提交的，因此您应该预计下一个评级将在2024年8月3日左右公布。
Is the Analyst Rating GlycoMimetics (GLYC) correct?
分析师对 GlycoMimetics (GLYC) 的评级正确吗？
While ratings are subjective and will change, the latest GlycoMimetics (GLYC) rating was a reiterated with a price target of $0.00 to $8.00. The current price GlycoMimetics (GLYC) is trading at is $1.59, which is within the analyst's predicted range.
虽然评级是主观的，会发生变化，但最新的GlycoMimetics（GLYC）评级得到重申，目标股价为0.00美元至8.00美元。GlycoMimetics（GLYC）目前的交易价格为1.59美元，在分析师的预测区间内。